IMPACT ALS Europe – extended deadline: December 31

30 October 2020

Are you an ALS/MND patient or caregiver? We need your help!

Take a survey to help guide drug development and services for amyotrophic lateral sclerosis (ALS)/motor neurone disease (MND).

Please click on the flyer below or follow the link on the bottom of this page to access the survey. For any inquiries, please contact ALS_Survey_Europe@apothecom.com

 

 

Go to survey